Pharmacology for Nurses
by Openstax
Pharmacology for Nurses is intended for nursing students in an introductory program. It provides a fundamental understanding of the therapeutic use of drugs, so the nurse can provide safe and effective care to the client. Along with a discussion of each body system, the text also reviews the pathophysiology of various disease processes and medications used in treatment.
Description from LibreTexts.
- Publisher
- LibreTexts
- Subjects
- Medicine, Nursing
- Licence
- CC BY 4.0, as LibreTexts states it
- Who can read
- Teens profiles and older, judged from its title and subjects
Contents
LibreTexts writes equations in TeX, and here they show as TeX; the PDF has them typeset.
- Front Matter
- TitlePage
- InfoPage
- Table of Contents
- Licensing
- 1: Introduction to Pharmacology
- 1.0: Introduction
- 1.1: Pharmacology, Interdisciplinary Teams, and Nursing Practice
- 1.2: Drug Sources, Forms, and Names
- 1.3: Drug Classifications and Prototypes
- 1.4: Special Considerations
- 1.5: Chapter Summary
- 1.6: Key Terms
- 1.7: Review Questions
- 2: Drug Administration
- 2.0: Introduction
- 2.1: Drug Administration and the Nursing Process
- 2.2: Pharmacokinetics and Pharmacodynamics
- 2.3: Drug Administration Routes, Preparation, and Administration
- 2.4: Dosage Calculations
- 2.5: Chapter Summary
- 2.6: Key Terms
- 2.7: Review Questions
- 3: Ethics, Legal Considerations, and Safety
- 3.0: Introduction
- 3.1: Legal Considerations
- 3.2: Drug Errors and Prevention
- 3.3: Documentation and Informatics
- 3.4: Chapter Summary
- 3.5: Key Terms
- 3.6: Review Questions
- 4: Introduction to Homeostasis
- 4.0: Introduction
- 4.1: What Is Homeostasis?
- 4.2: Osmolality
- 4.3: Maintaining Homeostasis
- 4.4: Negative Feedback Loop
- 4.5: Chapter Summary
- 4.6: Key Terms
- 4.7: Review Questions
- 5: Fluids and Electrolytes, Vitamins, Minerals, and Alternative Therapies
- 5.0: Introduction
- 5.1: Fluid Volume
- 5.2: Electrolytes
- 5.3: Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
- 5.4: Vitamins, Minerals, and Complementary and Alternative Therapies
- 5.5: Chapter Summary
- 5.6: Key Terms
- 5.7: Review Questions
- 6: Introduction to the Immune System and the Inflammatory Response
- 6.0: Introduction
- 6.1: Introduction to Immunity
- 6.2: Vaccine-Preventable Diseases, Vaccines, and Immunizations
- 6.3: Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
- 6.4: Introduction to the Inflammatory Response and Anti-inflammatory Drugs
- 6.5: Chapter Summary
- 6.6: Key Terms
- 6.7: Review Questions
- 7: Anti-Infective Drugs
- 7.0: Introduction
- 7.1: Introduction to Bacterial, Viral/COVID-19, and Fungal Infections
- 7.2: Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
- 7.3: Introduction to HIV, AIDS, and Antiretrovirals
- 7.4: Introduction to Sexually Transmitted Infections and Drugs to Treat Them
- 7.5: Introduction to Tuberculosis and Antitubercular Drugs
- 7.6: Antiparasitic and Anthelminthic Drugs
- 7.7: Chapter Summary
- 7.8: Key Terms
- 7.9: Review Questions
- 8: Introduction to Cancer Therapy and Cancer Drugs
- 8.0: Introduction
- 8.1: Introduction to Cancer and Phases of Cancer Therapy
- 8.2: Chemotherapeutic Drugs
- 8.3: Hormonal Therapy
- 8.4: Biologic Response Modifiers
- 8.5: Chapter Summary
- 8.6: Key Terms
- 8.7: Review Questions
- 9: Introduction to the Nervous System
- 9.0: Introduction
- 9.1: Introduction to the Nervous System
- 9.2: Structure and Function of the Nervous System
- 9.3: Characteristics of Drugs to Treat Nervous System Disorders
- 9.4: Chapter Summary
- 9.5: Key Terms
- 9.6: Review Questions
- 10: Drugs to Treat Myasthenia Gravis and Alzheimer’s Disease
- 10.0: Introduction
- 10.1: Introduction to Myasthenia Gravis
- 10.2: Cholinergic Drugs
- 10.3: Introduction to Alzheimer's Disease
- 10.4: Alzheimer’s Drugs
- 10.5: Chapter Summary
- 10.6: Key Terms
- 10.7: Review Questions
- 11: Drugs to Treat Parkinson’s Disease and Multiple Sclerosis
- 11.0: Introduction
- 11.1: Introduction to Parkinson’s Disease
- 11.2: Anti-Parkinsonian Drugs
- 11.3: Introduction to Multiple Sclerosis
- 11.4: Drugs Used in the Treatment of Multiple Sclerosis
- 11.5: Chapter Summary
- 11.6: Key Terms
- 11.7: Review Questions
- 12: Anticonvulsant Drugs and Drugs to Treat Epilepsy, Migraine Headaches, and Intracranial Emergencies
- 12.0: Introduction
- 12.1: Epilepsy and Anticonvulsant Drugs
- 12.2: Migraine Headaches and Migraine Headache Drugs
- 12.3: Intracranial Emergencies and Intracranial Emergency Drugs
- 12.4: Chapter Summary
- 12.5: Key Terms
- 12.6: Review Questions
- 13: Psychopharmacologic Drugs
- 13.0: Introduction
- 13.1: Antidepressants
- 13.2: Antipsychotics
- 13.3: Mood Stabilizers
- 13.4: Anxiolytics and Sedative-Hypnotics
- 13.5: CNS Stimulants and Nonstimulants
- 13.6: Chapter Summary
- 13.7: Key Terms
- 13.8: Review Questions
- 14: Pain Response Drugs
- 14.0: Introduction
- 14.1: Introduction to Pain
- 14.2: Nonopioid Analgesics
- 14.3: Opioid Agonists and Antagonists
- 14.4: Chapter Summary
- 14.5: Key Terms
- 14.6: Review Questions
- 15: Substance Use Disorder Treatment Drugs
- 15.0: Introduction
- 15.1: Introduction to Substance Use Disorders
- 15.2: Opioid Use Disorder Drugs
- 15.3: Alcohol Use Disorder Drugs
- 15.4: Nicotine Use Disorder Drugs
- 15.5: Chapter Summary
- 15.6: Key Terms
- 15.7: Review Questions
- 16: Introduction to the Cardiovascular System
- 16.0: Introduction
- 16.1: Introduction to the Heart, Circulation, and Blood Flow
- 16.2: Pumping Action of the Heart
- 16.3: Conduction of Electrical Impulses
- 16.4: Chapter Summary
- 16.5: Key Terms
- 16.6: Review Questions
- 17: Antidysrhythmic Drugs
- 17.0: Introduction
- 17.1: Introduction to Dysrhythmias
- 17.2: Class I- Sodium Channel Blockers
- 17.3: Class II- Beta Adrenergic Blockers
- 17.4: Class III- Potassium Channel Blockers
- 17.5: Class IV- Calcium Channel Blockers
- 17.6: Unclassified Antidysrhythmics
- 17.7: Chapter Summary
- 17.8: Key Terms
- 17.9: Review Questions
- 18: Antihypertensive and Antianginal Drugs
- 18.0: Introduction
- 18.1: Hypertension and Angina
- 18.2: Angiotensin-Converting Enzyme (ACE) Inhibitors
- 18.3: Angiotensin II Receptor Blockers (ARBs)
- 18.4: Beta-Adrenergic Blockers
- 18.5: Calcium Channel Blockers
- 18.6: Diuretics
- 18.7: Nitrates
- 18.8: Chapter Summary
- 18.9: Key Terms
- 18.10: Review Questions
- 19: Heart Failure Drugs
- 19.0: Introduction
- 19.1: Heart Failure
- 19.2: Drugs Affecting the Renin-Angiotensin-Aldosterone System
- 19.3: Beta-Adrenergic Blockers
- 19.4: Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is)
- 19.5: Diuretics
- 19.6: Adjunct Medications Used in Heart Failure
- 19.7: Chapter Summary
- 19.8: Key Terms
- 19.9: Review Questions
- 20: Anticoagulant, Antiplatelet, and Thrombolytic Drugs
- 20.0: Introdcution
- 20.1: Introduction to Clotting and Coagulation
- 20.2: Anticoagulants
- 20.3: Antiplatelets
- 20.4: Thrombolytics
- 20.5: Chapter Summary
- 20.6: Key Terms
- 20.7: Review Questions
- 21: Lipid-Lowering Drugs
- 21.0: Introduction
- 21.1: Introduction to Lipoprotein and Apolipoproteins
- 21.2: Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
- 21.3: Bile Acid Sequestrants, Fibrates, and Niacin
- 21.4: Cholesterol Absorption Inhibitors
- 21.5: Chapter Summary
- 21.6: Key Terms
- 21.7: Review Questions
- 22: Cardiac Emergency and Shock Drugs
- 22.0: Introduction
- 22.1: Introduction to Cardiac Emergencies and Shock
- 22.2: Cardiac Emergency Drugs
- 22.3: Shock Drugs
- 22.4: Chapter Summary
- 22.5: Key Terms
- 22.6: Review Questions
- 23: Introduction to the Respiratory System
- 23.0: Introduction
- 23.1: Introduction to the Upper Respiratory System
- 23.2: Introduction to the Lower Respiratory System
- 23.3: Oxygenation and Gas Exchange
- 23.4: Chapter Summary
- 23.5: Key Terms
- 23.6: Review Questions
- 24: Upper Respiratory Disorder Drugs
- 24.0: Introduction
- 24.1: Antihistamines and Decongestants
- 24.2: Antitussives
- 24.3: Expectorants and Mucolytics
- 24.4: Chapter Summary
- 24.5: Key Terms
- 24.6: Review Questions
- 25: Lower Respiratory Disorder Drugs
- 25.0: Introduction
- 25.1: Adrenergics and Anticholinergics
- 25.2: Corticosteroids
- 25.3: Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
- 25.4: Chapter Summary
- 25.5: Key Terms
- 25.6: Review Questions
- 26: Hypothalamus, Pituitary, and Adrenal Disorder Drugs
- 26.0: Introduction
- 26.1: Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
- 26.2: Growth Hormones and Suppressants
- 26.3: Antidiuretic Hormones
- 26.4: Glucocorticoids and Mineralocorticoids
- 26.5: Chapter Summary
- 26.6: Key Terms
- 26.7: Review Questions
- 27: Thyroid and Parathyroid Disorder Drugs
- 27.0: Introduction
- 27.1: Introduction to the Thyroid and Parathyroid
- 27.2: Thyroid and Antithyroid Drugs
- 27.3: Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
- 27.4: Chapter Summary
- 27.5: Key Terms
- 27.6: Review Questions
- 28: Diabetic Drugs
- 28.0: Introduction
- 28.1: Introduction to Diabetes
- 28.2: Insulin and Non-Insulin Injectable Diabetes Drugs
- 28.3: Oral Antidiabetic Drugs
- 28.4: Chapter Summary
- 28.5: Key Terms
- 28.6: Review Questions
- 29: Introduction to the Digestive System
- 29.0: Introduction
- 29.1: Introduction to the Gastrointestinal System and Oral Cavity
- 29.2: Introduction to the Esophagus and Stomach
- 29.3: Introduction to the Small and Large Intestines
- 29.4: Chapter Summary
- 29.5: Key Terms
- 29.6: Review Questions
- 30: Gastrointestinal Disorder Drugs
- 30.0: Introduction
- 30.1: Antiemetics
- 30.2: Antidiarrheals
- 30.3: Laxatives and Stool Softeners
- 30.4: Chapter Summary
- 30.5: Key Terms
- 30.6: Review Questions
- 31: Hyperacidity and Antiulcer Drugs
- 31.0: Introduction
- 31.1: Antacids
- 31.2: Histamine Blockers and Proton-Pump Inhibitors
- 31.3: Pepsin Inhibitors and Prostaglandin Analogues
- 31.4: Chapter Summary
- 31.5: Key Terms
- 31.6: Review Questions
- 32: Weight Management Drugs
- 32.0: Introduction
- 32.1: Introduction to Weight Management
- 32.2: Anorexiants
- 32.3: Lipase Inhibitors
- 32.4: Other Drugs, Supplements, and Herbal Remedies
- 32.5: Chapter Summary
- 32.6: Key Terms
- 32.7: Review Questions
- 33: Introduction to the Renal and Urinary Systems
- 33.0: Introduction
- 33.1: Introduction to the Renal System
- 33.2: Renal-Associated Fluid Volume Excess
- 33.3: Introduction to the Urinary System
- 33.4: Chapter Summary
- 33.5: Key Terms
- 33.6: Review Questions
- 34: Diuretic Drugs
- 34.0: Introduction
- 34.1: Introduction to Diuretics
- 34.2: Loop Diuretics
- 34.3: Osmotic Diuretics
- 34.4: Potassium-Sparing Diuretics
- 34.5: Thiazide and Thiazide-Like Diuretics
- 34.6: Chapter Summary
- 34.7: Key Terms
- 34.8: Review Questions
- 35: Urinary and Bladder Disorder Drugs
- 35.0: Introduction
- 35.1: Urinary Anti-infectives
- 35.2: Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
- 35.3: Urinary Analgesics
- 35.4: Urinary Stimulants
- 35.5: Phosphodiesterase 5 Inhibitors
- 35.6: Chapter Summary
- 35.7: Key Terms
- 35.8: Review Questions
- 36: Reproductive Health Drugs
- 36.0: Introduction
- 36.1: Review of the Female Reproductive System
- 36.2: Hormonal, Contraception, and Infertility Drugs
- 36.3: Uterine Motility Drugs and Lactation Considerations
- 36.4: Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
- 36.5: Review of the Male Reproductive System
- 36.6: Androgens, Antiandrogens, and Anabolic Steroids
- 36.7: Phosphodiesterase 5 Inhibitors
- 36.8: Alpha Blockers and 5-Alpha-Reductase Inhibitors
- 36.9: Chapter Summary
- 36.10: Key Terms
- 36.11: Review Questions
- 37: Transgender and Nonbinary Drugs
- 37.0: Introduction
- 37.1: Overview of Transgender and Nonbinary Health
- 37.2: Feminizing Hormonal Therapy
- 37.3: Masculinizing Hormonal Therapy
- 37.4: Chapter Summary
- 37.5: Key Terms
- 37.6: Review Questions
- 38: Ophthalmic Drugs
- 38.0: Introduction
- 38.1: Introduction to the Eyes
- 38.2: Ocular Anti-inflammatories and Anti-infectives
- 38.3: Ocular Anesthetics and Lubricants
- 38.4: Antiglaucoma Drugs
- 38.5: Chapter Summary
- 38.6: Key Terms
- 38.7: Review Questions
- 39: Otic Drugs
- 39.0: Introduction
- 39.1: Introduction to the Ears
- 39.2: Otic Anti-inflammatories and Anti-infectives
- 39.3: Otic Antihistamines, Decongestants, and Cerumenolytics
- 39.4: Chapter Summary
- 39.5: Key Terms
- 39.6: Review Questions
- 40: Dermatologic Disorder Drugs
- 40.0: Introduction
- 40.1: Introduction to the Skin and Its Function
- 40.2: Acne Drugs
- 40.3: Psoriatic Drugs
- 40.4: Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
- 40.5: Chapter Summary
- 40.6: Key Terms
- 40.7: Review Questions
- 41: Appendix
- 41.0: Appendix A- International System of Units
- 41.1: Appendix B- Common Abbreviations and Lab Values
- 41.2: Appendix C- Drug Conversion Tables
- 41.3: Answer Key
- 41.3.0: Chapter 1
- 41.3.1: Chapter 2
- 41.3.2: Chapter 3
- 41.3.3: Chapter 4
- 41.3.4: Chapter 5
- 41.3.5: Chapter 6
- 41.3.6: Chapter 7
- 41.3.7: Chapter 8
- 41.3.8: Chapter 9
- 41.3.9: Chapter 10
- 41.3.10: Chapter 11
- 41.3.11: Chapter 12
- 41.3.12: Chapter 13
- 41.3.13: Chapter 14
- 41.3.14: Chapter 15
- 41.3.15: Chapter 16
- 41.3.16: Chapter 17
- 41.3.17: Chapter 18
- 41.3.18: Chapter 19
- 41.3.19: Chapter 20
- 41.3.20: Chapter 21
- 41.3.21: Chapter 22
- 41.3.22: Chapter 23
- 41.3.23: Chapter 24
- 41.3.24: Chapter 25
- 41.3.25: Chapter 26
- 41.3.26: Chapter 27
- 41.3.27: Chapter 28
- 41.3.28: Chapter 29
- 41.3.29: Chapter 30
- 41.3.30: Chapter 31
- 41.3.31: Chapter 32
- 41.3.32: Chapter 33
- 41.3.33: Chapter 34
- 41.3.34: Chapter 35
- 41.3.35: Chapter 36
- 41.3.36: Chapter 37
- 41.3.37: Chapter 38
- 41.3.38: Chapter 39
- 41.3.39: Chapter 40
- 41.4: References
- Back Matter
- Index
- Glossary
- Detailed Licensing
- Detailed Licensing